Terms: = Pancreatic cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Diagnosis
40 results:
1. HIV associated malignancies presenting as acute pancreatitis: a case series.
Madela F; Anderson F; Nhlonzi GB; Thomson SR
S Afr J Surg; 2023 Nov; 61(4):234-236. PubMed ID: 38450696
[TBL] [Abstract] [Full Text] [Related]
2. Early-Onset pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes.
Pulvirenti A; Hauser HF; Fiedler LM; McIntyre CA; Le T; Reidy-Lagunes DL; Soares KC; Balachandran VP; Kingham TP; D'Angelica MI; Drebin JA; Jarnagin WR; Raj N; Wei AC
Ann Surg; 2024 Jan; 279(1):125-131. PubMed ID: 37325926
[TBL] [Abstract] [Full Text] [Related]
3. Association of Radiation and Procarbazine Dose With Risk of Colorectal cancer Among Survivors of Hodgkin Lymphoma.
Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
[TBL] [Abstract] [Full Text] [Related]
4. Epithelioid Inflammatory Myofibroblastic Sarcoma with Leukemoid Reaction.
Wan YY; Miao CL; Liu SB; Zhang T; Luo CH
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1212-1215. PubMed ID: 36089724
[TBL] [Abstract] [Full Text] [Related]
5. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
Unnisa A; Chettupalli AK; Hussain T; Kamal MA
Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
[TBL] [Abstract] [Full Text] [Related]
6. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract] [Full Text] [Related]
7. [Comparative clinical efficacy analysis of pancreatoduodenectomy for distal bile duct and pancreatic head cancer: a report of 1 005 cases].
Wu PF; Zhang K; Lu ZP; Lin JZ; Chen JM; Xi CH; Wei JS; Guo F; Tu M; Jiang KR; Miao Y
Zhonghua Wai Ke Za Zhi; 2022 Feb; 60(2):128-133. PubMed ID: 35012271
[No Abstract] [Full Text] [Related]
8. Primary alk-Positive Large B Cell Lymphoma of Pancreas.
Kushwaha P; Singh M; Vindal A; Verma N; Jain S
J Gastrointest Cancer; 2022 Sep; 53(3):830-833. PubMed ID: 34374890
[TBL] [Abstract] [Full Text] [Related]
9. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma.
Mao F; Duan H; Allamyradov A; Xin Z; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
Aging (Albany NY); 2021 Jan; 13(3):4096-4114. PubMed ID: 33493138
[TBL] [Abstract] [Full Text] [Related]
10. Diabetes, Weight Change, and pancreatic cancer Risk.
Yuan C; Babic A; Khalaf N; Nowak JA; Brais LK; Rubinson DA; Ng K; Aguirre AJ; Pandharipande PV; Fuchs CS; Giovannucci EL; Stampfer MJ; Rosenthal MH; Sander C; Kraft P; Wolpin BM
JAMA Oncol; 2020 Oct; 6(10):e202948. PubMed ID: 32789511
[TBL] [Abstract] [Full Text] [Related]
11. Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors.
Li J; Jiang W; Wei J; Zhang J; Cai L; Luo M; Wang Z; Sun W; Wang S; Wang C; Dai C; Liu J; Wang G; Wang J; Xu Q; Deng Y
J Transl Med; 2020 Aug; 18(1):293. PubMed ID: 32738923
[TBL] [Abstract] [Full Text] [Related]
12.
Valencia-Sama I; Ladumor Y; Kee L; Adderley T; Christopher G; Robinson CM; Kano Y; Ohh M; Irwin MS
Cancer Res; 2020 Aug; 80(16):3413-3423. PubMed ID: 32586982
[TBL] [Abstract] [Full Text] [Related]
13. Increased psychological symptom burden in patients with pancreatic cancer: A population-based cohort study.
Dengsø KE; Andersen EW; Thomsen T; Hansen CP; Christensen BM; Hillingsø J; Dalton SO
Pancreatology; 2020 Apr; 20(3):511-521. PubMed ID: 31973981
[TBL] [Abstract] [Full Text] [Related]
14. Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Ma H; Song B; Guo S; Li G; Jin G
Cancer Biomark; 2020; 27(3):389-397. PubMed ID: 31958074
[TBL] [Abstract] [Full Text] [Related]
15. Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network.
Liu SL; Li S; Guo YT; Zhou YP; Zhang ZD; Li S; Lu Y
Chin Med J (Engl); 2019 Dec; 132(23):2795-2803. PubMed ID: 31856050
[TBL] [Abstract] [Full Text] [Related]
16. Significance and prognostic value of increased serum direct bilirubin level for lymph node metastasis in Chinese rectal cancer patients.
Gao C; Fang L; Li JT; Zhao HC
World J Gastroenterol; 2016 Feb; 22(8):2576-84. PubMed ID: 26937145
[TBL] [Abstract] [Full Text] [Related]
17. Incidence of Second Primary Malignancies in Patients with Neuroendocrine Tumours.
Clift AK; Drymousis P; Al-Nahhas A; Wasan H; Martin J; Holm S; Frilling A
Neuroendocrinology; 2015; 102(1-2):26-32. PubMed ID: 25824138
[TBL] [Abstract] [Full Text] [Related]
18. Alterations of a spectrum of driver genes in female Chinese patients with advanced or metastatic squamous cell carcinoma of the lung.
Qiong Z; Na WY; Bo W; Zhu Z; Ling P; Bo MH; Min TY; Lei Z; Na HD; Bo Z; Fang LJ; Seng ZS
Lung Cancer; 2015 Feb; 87(2):117-21. PubMed ID: 25488863
[TBL] [Abstract] [Full Text] [Related]
19. Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma.
Wang X; Li Y; Tian H; Qi J; Li M; Fu C; Wu F; Wang Y; Cheng D; Zhao W; Zhang C; Wang T; Rao J; Zhang W
BMC Cancer; 2014 Aug; 14():578. PubMed ID: 25106741
[TBL] [Abstract] [Full Text] [Related]
20. Safety and Tolerability of Linagliptin in Patients With Type 2 Diabetes: A Comprehensive Pooled Analysis of 22 Placebo-controlled Studies.
Lehrke M; Marx N; Patel S; Seck T; Crowe S; Cheng K; von Eynatten M; Johansen OE
Clin Ther; 2014 Aug; 36(8):1130-46. PubMed ID: 25015594
[TBL] [Abstract] [Full Text] [Related]
[Next]
